Fig. 5From: Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trialChange in anthropometric parameters. (A) Weight, (B) Body mass index (BMI) were measured in NAOs and placebo treated groups at baseline and 16 weeks. Values are presented as mean ± SD. Between-group differences were assessed using independent t-test for change value between the groups. **p < 0.01 vs. placebo group. NAOs, Neoagaro-oligosaccharides; BMI, body mass indexBack to article page